Literature DB >> 26729549

Gastrointestinal Findings in the Largest Series of Patients With Hereditary Biallelic Mismatch Repair Deficiency Syndrome: Report from the International Consortium.

Melyssa Aronson1, Steven Gallinger1, Zane Cohen1, Shlomi Cohen2, Rina Dvir3, Ronit Elhasid3, Hagit N Baris4, Revital Kariv5, Harriet Druker6, Helen Chan6, Simon C Ling6,7, Paul Kortan8, Spring Holter1, Kara Semotiuk1, David Malkin6,7, Roula Farah9, Alain Sayad10, Brandie Heald11, Matthew F Kalady11, Lynette S Penney12, Andrea L Rideout12, Mohsin Rashid12, Linda Hasadsri13, Pavel Pichurin13, Douglas Riegert-Johnson14, Brittany Campbell6, Doua Bakry6, Hala Al-Rimawi15, Qasim Kholaif Alharbi16, Musa Alharbi17, Ashraf Shamvil18, Uri Tabori6,7, Carol Durno1,6.   

Abstract

OBJECTIVES: Hereditary biallelic mismatch repair deficiency (BMMRD) is caused by biallelic mutations in the mismatch repair (MMR) genes and manifests features of neurofibromatosis type 1, gastrointestinal (GI) polyposis, and GI, brain, and hematological cancers. This is the first study to characterize the GI phenotype in BMMRD using both retrospective and prospective surveillance data.
METHODS: The International BMMRD Consortium was created to collect information on BMMRD families referred from around the world. All patients had germline biallelic MMR mutations or lack of MMR protein staining in normal and tumor tissue. GI screening data were obtained through medical records with annual updates.
RESULTS: Thirty-five individuals from seven countries were identified with BMMRD. GI data were available on 24 of 33 individuals (73%) of screening age, totaling 53 person-years. The youngest age of colonic adenomas was 7, and small bowel adenoma was 11. Eight patients had 19 colorectal adenocarcinomas (CRC; median age 16.7 years, range 8-25), and 11 of 18 (61%) CRC were distal to the splenic flexure. Eleven patients had 15 colorectal surgeries (median 14 years, range 9-25). Four patients had five small bowel adenocarcinomas (SBC; median 18 years, range 11-33). Two CRC and two SBC were detected during surveillance within 6-11 months and 9-16 months, respectively, of last consecutive endoscopy. No patient undergoing surveillance died of a GI malignancy. Familial clustering of GI cancer was observed.
CONCLUSIONS: The prevalence and penetrance of GI neoplasia in children with BMMRD is high, with rapid development of carcinoma. Colorectal and small bowel surveillance should commence at ages 3-5 and 8 years, respectively.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26729549     DOI: 10.1038/ajg.2015.392

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  43 in total

1.  Homozygous PMS2 deletion causes a severe colorectal cancer and multiple adenoma phenotype without extraintestinal cancer.

Authors:  Olivia Will; Luis G Carvajal-Carmona; Patricia Gorman; Kimberley M Howarth; Angela M Jones; Guadalupe M Polanco-Echeverry; Jo-Anne Chinaleong; Thomas Günther; Andrew Silver; Susan K Clark; Ian Tomlinson
Journal:  Gastroenterology       Date:  2006-11-29       Impact factor: 22.682

2.  Childhood T-cell non-Hodgkin's lymphoma, colorectal carcinoma and brain tumor in association with café-au-lait spots caused by a novel homozygous PMS2 mutation.

Authors:  C P Kratz; C M Niemeyer; E Jüttner; M Kartal; A Weninger; A Schmitt-Graeff; U Kontny; M Lauten; S Utzolino; J Rädecke; C Fonatsch; K Wimmer
Journal:  Leukemia       Date:  2007-11-15       Impact factor: 11.528

3.  Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.

Authors:  Doua Bakry; Melyssa Aronson; Carol Durno; Hala Rimawi; Roula Farah; Qasim Kholaif Alharbi; Musa Alharbi; Ashraf Shamvil; Shay Ben-Shachar; Matthew Mistry; Shlomi Constantini; Rina Dvir; Ibrahim Qaddoumi; Steven Gallinger; Jordan Lerner-Ellis; Aaron Pollett; Derek Stephens; Steve Kelies; Elizabeth Chao; David Malkin; Eric Bouffet; Cynthia Hawkins; Uri Tabori
Journal:  Eur J Cancer       Date:  2014-01-15       Impact factor: 9.162

4.  Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene.

Authors:  M De Rosa; C Fasano; L Panariello; M I Scarano; G Belli; A Iannelli; F Ciciliano; P Izzo
Journal:  Oncogene       Date:  2000-03-23       Impact factor: 9.867

5.  Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium "Care for CMMR-D" (C4CMMR-D).

Authors:  H F A Vasen; Z Ghorbanoghli; F Bourdeaut; O Cabaret; O Caron; A Duval; N Entz-Werle; Y Goldberg; D Ilencikova; C P Kratz; N Lavoine; J Loeffen; F H Menko; M Muleris; G Sebille; C Colas; B Burkhardt; L Brugieres; K Wimmer
Journal:  J Med Genet       Date:  2014-02-20       Impact factor: 6.318

Review 6.  Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?

Authors:  Katharina Wimmer; Julia Etzler
Journal:  Hum Genet       Date:  2008-08-18       Impact factor: 4.132

7.  Café-au-lait spots and early onset colorectal neoplasia: a variant of HNPCC?

Authors:  J D Trimbath; G M Petersen; S H Erdman; M Ferre; M C Luce; F M Giardiello
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

8.  Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation.

Authors:  Steven Gallinger; Melyssa Aronson; Katayoon Shayan; Elyanne M Ratcliffe; Justin T Gerstle; Patricia C Parkin; Heidi Rothenmund; Marina Croitoru; Ewa Baumann; Peter R Durie; Rosanna Weksberg; Aaron Pollett; Robert H Riddell; Bo Y Ngan; Ernest Cutz; Alain E Lagarde; Helen S L Chan
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

9.  A homozygote splice site PMS2 mutation as cause of Turcot syndrome gives rise to two different abnormal transcripts.

Authors:  Wenche Sjursen; Inga Bjørnevoll; Lars F Engebretsen; Kristine Fjelland; Tore Halvorsen; Helge E Myrvold
Journal:  Fam Cancer       Date:  2008-11-28       Impact factor: 2.375

10.  Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation.

Authors:  Jessie Auclair; Dominique Leroux; Françoise Desseigne; Christine Lasset; Jean Christophe Saurin; Marie Odile Joly; Stéphane Pinson; Xiao Li Xu; Gilles Montmain; Eric Ruano; Claudine Navarro; Alain Puisieux; Qing Wang
Journal:  Hum Mutat       Date:  2007-11       Impact factor: 4.878

View more
  9 in total

1.  Neuroimaging Findings in Children with Constitutional Mismatch Repair Deficiency Syndrome.

Authors:  A Kerpel; M Yalon; M Soudack; J Chiang; A Gajjar; K E Nichols; Z Patay; S Shrot; C Hoffmann
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-30       Impact factor: 3.825

2.  Leveraging premalignant biology for immune-based cancer prevention.

Authors:  Avrum Spira; Mary L Disis; John T Schiller; Eduardo Vilar; Timothy R Rebbeck; Rafael Bejar; Trey Ideker; Janine Arts; Matthew B Yurgelun; Jill P Mesirov; Anjana Rao; Judy Garber; Elizabeth M Jaffee; Scott M Lippman
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-16       Impact factor: 11.205

3.  Elucidating the clinical significance of two PMS2 missense variants coexisting in a family fulfilling hereditary cancer criteria.

Authors:  Maribel González-Acosta; Jesús Del Valle; Matilde Navarro; Bryony A Thompson; Sílvia Iglesias; Xavier Sanjuan; María José Paúles; Natàlia Padilla; Anna Fernández; Raquel Cuesta; Àlex Teulé; Guido Plotz; Juan Cadiñanos; Xavier de la Cruz; Francesc Balaguer; Conxi Lázaro; Marta Pineda; Gabriel Capellá
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

Review 4.  How many is too many? Polyposis syndromes and what to do next.

Authors:  Nina Gupta; Christine Drogan; Sonia S Kupfer
Journal:  Curr Opin Gastroenterol       Date:  2022-01-01       Impact factor: 3.287

Review 5.  Recent progress in Lynch syndrome and other familial colorectal cancer syndromes.

Authors:  Patrick M Boland; Matthew B Yurgelun; C Richard Boland
Journal:  CA Cancer J Clin       Date:  2018-02-27       Impact factor: 508.702

6.  Immune Checkpoint Inhibition as Primary Adjuvant Therapy for an IDH1-Mutant Anaplastic Astrocytoma in a Patient with CMMRD: A Case Report-Usage of Immune Checkpoint Inhibition in CMMRD.

Authors:  Rebekah Rittberg; Craig Harlos; Heidi Rothenmund; Anirban Das; Uri Tabori; Namita Sinha; Harminder Singh; Bernie Chodirker; Christina A Kim
Journal:  Curr Oncol       Date:  2021-02-01       Impact factor: 3.677

7.  Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing Surveillance.

Authors:  Carol Durno; Ayse Bahar Ercan; Vanessa Bianchi; Melissa Edwards; Melyssa Aronson; Melissa Galati; Eshetu G Atenafu; Gadi Abebe-Campino; Abeer Al-Battashi; Musa Alharbi; Vahid Fallah Azad; Hagit N Baris; Donald Basel; Raymond Bedgood; Anne Bendel; Shay Ben-Shachar; Deborah T Blumenthal; Maude Blundell; Miriam Bornhorst; Annika Bronsema; Elizabeth Cairney; Sara Rhode; Shani Caspi; Aghiad Chamdin; Stefano Chiaravalli; Shlomi Constantini; Bruce Crooks; Anirban Das; Rina Dvir; Roula Farah; William D Foulkes; Zehavit Frenkel; Bailey Gallinger; Sharon Gardner; David Gass; Mithra Ghalibafian; Catherine Gilpin; Yael Goldberg; Catherine Goudie; Syed Ahmer Hamid; Heather Hampel; Jordan R Hansford; Craig Harlos; Nobuko Hijiya; Saunders Hsu; Junne Kamihara; Rejin Kebudi; Jeffrey Knipstein; Carl Koschmann; Christian Kratz; Valerie Larouche; Alvaro Lassaletta; Scott Lindhorst; Simon C Ling; Michael P Link; Rebecca Loret De Mola; Rebecca Luiten; Michal Lurye; Jamie L Maciaszek; Vanan MagimairajanIssai; Ossama M Maher; Maura Massimino; Rose B McGee; Naureen Mushtaq; Gary Mason; Monica Newmark; Garth Nicholas; Kim E Nichols; Theodore Nicolaides; Enrico Opocher; Michael Osborn; Benjamin Oshrine; Rachel Pearlman; Daniel Pettee; Jan Rapp; Mohsin Rashid; Alyssa Reddy; Lara Reichman; Marc Remke; Gabriel Robbins; Sumita Roy; Magnus Sabel; David Samuel; Isabelle Scheers; Kami Wolfe Schneider; Santanu Sen; Duncan Stearns; David Sumerauer; Carol Swallow; Leslie Taylor; Gregory Thomas; Helen Toledano; Patrick Tomboc; An Van Damme; Ira Winer; Michal Yalon; Lee Yi Yen; Michal Zapotocky; Shayna Zelcer; David S Ziegler; Stefanie Zimmermann; Cynthia Hawkins; David Malkin; Eric Bouffet; Anita Villani; Uri Tabori
Journal:  J Clin Oncol       Date:  2021-05-04       Impact factor: 50.717

8.  A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency.

Authors:  Katharina Wimmer; Andreas Beilken; Rainer Nustede; Tim Ripperger; Britta Lamottke; Benno Ure; Diana Steinmann; Tanja Reineke-Plaass; Ulrich Lehmann; Johannes Zschocke; Laura Valle; Christine Fauth; Christian P Kratz
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

9.  Role of video capsule endoscopy in patients with constitutional mismatch repair deficiency (CMMRD) syndrome: report from the International CMMRD Consortium.

Authors:  Y Shimamura; C M Walsh; S Cohen; M Aronson; U Tabori; P P Kortan; C A Durno
Journal:  Endosc Int Open       Date:  2018-08-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.